US Ecology Announces Schedule for Its Third Quarter 2021 Earnings Release and Conference Call

Written by Customer Service on October 18, 2021. Posted in Earnings Releases And Operating Results.

Announces Participation in Upcoming Investor Conferences BOISE, Idaho, Oct. 18, 2021 (GLOBE NEWSWIRE) — US Ecology, Inc. (the “Company”) [NASDAQ: ECOL] today announced that it will release financial results for the third quarter ended September 30, 2021 before market open on Friday, November 5, 2021. Management will also conduct an investor conference call on Friday, November 5, 2021 at 11:00 a.m. Eastern Time (9:00 a.m. Mountain Time) to discuss these results. Questions will be invited after management’s presentation. Interested parties can access the conference call by dialing 877-512-4138 or 412-317-5478. The conference call will also be broadcast live on the Company’s website at http://investors.usecology.com/events-and-presentations.aspx. An audio replay of the teleconference will be made available through November 12, 2021...

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2021 Financial and Operating Results and Provides Business Update

Written by Customer Service on October 18, 2021. Posted in Earnings Releases And Operating Results.

We expect Rafael Pharmaceuticals to report top line data from its AVENGER 500 Phase 3 registrational clinical trial in metastatic pancreatic cancer this calendar year We expect to submit our previously announced merger with Rafael Pharmaceuticals to our stockholders for a vote this calendar year The second and final interim futility analysis of Rafael Pharmaceuticals’ Phase 3 clinical trial in AML is planned for this calendar year On August 24, 2021, we closed a private investment in public equity (PIPE) financing and received net proceeds of approximately $97.8 million NEWARK, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) — Rafael Holdings, Inc., (NYSE: RFL), is focused on developing novel cancer metabolism therapeutics through its Barer Institute, investment in Rafael Pharmaceuticals, Inc. (“Rafael Pharmaceuticals”), a privately held,...

Plains’ Cushing Terminal to Become Delivery Point for the Benchmark WTI Crude Oil Futures Contract

Written by Customer Service on October 18, 2021. Posted in Public Companies.

HOUSTON, Oct. 18, 2021 (GLOBE NEWSWIRE) — Plains All American (Nasdaq: PAA & PAGP) (“Plains”) today announced that CME Group (Nasdaq: CME) (“CME”) will add Plains’ Cushing Terminal as a delivery point to the NYMEX WTI Crude Oil Futures contract, offering market participants an additional outlet to utilize the delivery mechanism of the world’s most liquid crude oil futures benchmark. The change will take effect November 8th, 2021 for the February 2022 contract month, pending regulatory review. Plains made its initial investment at Cushing, Oklahoma in the early 1990s and today is one of the largest operators at the Cushing hub. Cushing, Oklahoma is one of the leading crude oil market hubs in North America, and Plains appreciates CME’s recognition of Plains as one of the key liquidity points at the Cushing hub. Plains’...

Chicken Soup for the Soul Entertainment Announces Timing of Regular Monthly Dividend for November for Series A Cumulative Redeemable Perpetual Preferred Stock

Written by Customer Service on October 18, 2021. Posted in Dividend Reports And Estimates.

COS COB, Conn., Oct. 18, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE, CSSEP, CSSEN), one of the largest operators of streaming advertising-supported video-on-demand (“AVOD”) networks, today announced the timing for the payment of its declared regular monthly dividend of $0.2031 per share of its 9.75% Series A Cumulative Redeemable Perpetual Preferred Stock for November. The dividend will be payable on November 15, 2021 to holders of record as of October 31, 2021. The dividend will be paid in cash. ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENT Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”) operates streaming video-on-demand networks (VOD). The Company owns Crackle Plus, which owns and operates a variety of ad-supported and subscription-based VOD networks including...

Vivid Seats and Horizon Acquisition Corporation Announce Closing of Business Combination

Written by Customer Service on October 18, 2021. Posted in Mergers And Acquisitions.

CHICAGO, Oct. 18, 2021 (GLOBE NEWSWIRE) — Vivid Seats Inc. (“Vivid Seats” or the “Company”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, and Horizon Acquisition Corporation (“Horizon”), a publicly traded special purpose acquisition company, announced today the completion of their business combination (the “Business Combination”). The Business Combination was approved by a majority of Horizon stockholders at a special meeting held on October 14, 2021. Horizon has merged with and into Vivid Seats, with Vivid Seats as the surviving corporation. Beginning on October 19, 2021, Vivid Seats’ common stock and warrants are expected to begin trading on the NASDAQ Global Select Market (“NASDAQ”) under the ticker...

ServisFirst Bancshares, Inc. Announces Results for Third Quarter of 2021

Written by Customer Service on October 18, 2021. Posted in Earnings Releases And Operating Results.

BIRMINGHAM, Ala., Oct. 18, 2021 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc. (NYSE: SFBS), today announced earnings and operating results for the quarter ended September 30, 2021. Third Quarter 2021 Highlights: Total loans grew $163.1 million, or 8% annualized, during the quarter, while loans, excluding the impact of Paycheck Protection Program (“PPP”) loan forgiveness, grew $370.4 million, or 18% annualized, during the quarter Diluted earnings per share were $0.96 for the third quarter, an increase of 20% over the third quarter of 2020 Deposits grew from $9.67 billion to $12.08 billion year-over-year, or 25%, and grew $1.12 billion, or 41% annualized, on a linked-quarter basis Book value per share increased to $20.56, a 17% increase year-over-year Liquidity reached new record levels, with approximately $4.2 billion on deposit...

Iovance Biotherapeutics to Host Conference Call and Webcast to Highlight Data at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Written by Customer Service on October 18, 2021. Posted in Public Companies.

Oral Presentation of Clinical Data for TIL in Combination with Pembrolizumabin Immune-Checkpoint Inhibitor Naïve Patients with Advanced Cancers Poster for TIL Therapy in Advanced, Immune Checkpoint Inhibitor-Treated Non-Small Cell Lung Cancer (NSCLC) SAN CARLOS, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will host a webcast and conference call on Saturday, November 13, at 5:30 p.m. ET to discuss SITC clinical data updates for Iovance tumor-infiltrating lymphocyte (TIL) cell therapy in relapsed, refractory lung cancer as well as Iovance TIL in combination with pembrolizumab in patients with advanced cancers. Iovance senior leadership will be joined by key opinion leaders and principal investigators...

AAR signs contract with flydubai for continuing Boeing 737NG PBH Component Support

Written by Customer Service on October 18, 2021. Posted in Public Companies.

Wood Dale, Oct. 18, 2021 (GLOBE NEWSWIRE) — AAR (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs and OEMs, announced today that it signed an agreement with flydubai to renew its power-by-the-hour (PBH) component pool and repair support for the airline´s Next-Generation (NG) Boeing 737 fleet. The new five-year contract builds on a partnership that started in 2016 to provide comprehensive rotable component support for flydubai’s 737NG fleet. This renewal demonstrates flydubai’s trust in AAR and its recognition of the value AAR’s supply chain services bring to the Middle East’s fastest growing airline. “AAR has been a key partner and we would like to thank them for the support they have provided to our fleet over a number of years,” said Mick Hills, flydubai Senior Vice President, Engineering...

Capital Southwest Announces Second Quarter 2022 Earnings Release and Conference Call Schedule

Written by Customer Service on October 18, 2021. Posted in Public Companies.

Call Scheduled for 11:00 a.m. Eastern Time on Tuesday, November 2, 2021 DALLAS, Oct. 18, 2021 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest” or the “Company”; Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it will release its second quarter 2022 results on Monday, November 1, 2021 after the market closes. In conjunction with the release, Capital Southwest has scheduled a conference call which will be broadcast live via phone and over the Internet on Tuesday, November 2, 2021 at 11:00 a.m. Eastern time. Investors may participate either by phone or audio webcast. By Phone: Dial (866)-502-8274 and provide the operator with Conference ID 7789087 at least...

Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology

Written by Customer Service on October 18, 2021. Posted in Public Companies.

Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M in Initial Financing Provided by 5AM and Frazier Pipeline is Built from Crinetics’ Core Nonpeptide Platform and Includes Drug Candidates and Leads Against 10 Oncology Targets Radionetics and Crinetics to Collaborate on Multiple Additional targets SAN DIEGO, Oct. 18, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel nonpeptide therapeutics for rare endocrine diseases and endocrine-related tumors, together with 5AM Ventures and Frazier Healthcare Partners, today announced the formation of an independently operated new company, Radionetics Oncology. Radionetics aims to develop a deep pipeline of...

Day: October 18, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice